J
Joseph W. Becker
Researcher at Merck & Co.
Publications - 36
Citations - 3565
Joseph W. Becker is an academic researcher from Merck & Co.. The author has contributed to research in topics: Binding site & FKBP. The author has an hindex of 27, co-authored 36 publications receiving 3409 citations.
Papers
More filters
Journal ArticleDOI
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Jun Wang,Stephen M. Soisson,Katherine Young,Wesley L. Shoop,Wesley L. Shoop,Srinivas Kodali,Andrew Galgoci,Ronald E. Painter,Gopalakrishnan Parthasarathy,Yui S. Tang,Richard D. Cummings,Sookhee Ha,Karen Dorso,Mary Motyl,Hiranthi Jayasuriya,John G. Ondeyka,Kithsiri Herath,Chaowei Zhang,Lorraine D. Hernandez,John J. Allocco,Angela Basilio,José R. Tormo,Olga Genilloud,Francisca Vicente,Fernando Pelaez,Lawrence F. Colwell,Sang Ho Lee,B.F. Michael,Thomas J. Felcetto,Charles Gill,Lynn L. Silver,Lynn L. Silver,Jeffery D. Hermes,Ken Bartizal,John F. Barrett,Dennis M. Schmatz,Joseph W. Becker,Doris F. Cully,Sheo B. Singh +38 more
TL;DR: Platensimycin demonstrates strong, broad-spectrum Gram-positive antibacterial activity by selectively inhibiting cellular lipid biosynthesis through the selective targeting of β-ketoacyl-(acyl-carrier-protein (ACP) in the synthetic pathway of fatty acids.
Journal ArticleDOI
The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis.
Jennifer Rotonda,Donald W. Nicholson,Kimberly M. Fazil,Michel Gallant,Yves Gareau,Marc Labelle,Erin P. Peterson,Dita M. Rasper,Rejean Ruel,John P. Vaillancourt,Nancy A. Thornberry,Joseph W. Becker +11 more
TL;DR: The three-dimensional structure of a complex of the human CED-3 homologue CPP32/apopain with a potent tetrapeptide-aldehyde inhibitor is determined, finding that the protein resembles ICE in overall structure, but its S4 subsite is strikingly different in size and chemical composition.
Journal ArticleDOI
Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzyme
Joseph W. Becker,Alice I. Marcy,Laura Rokosz,Melinda G. Axel,Jonathan J. Burbaum,Paula M.D. Fitzgerald,Patricia M. Cameron,Craig K. Esser,William K. Hagmann,Jeffrey D. Hermes,James P. Springer +10 more
TL;DR: Comparison of the active site of stromelysin with that of thermolysin reveals that most of the residues proposed to play significant roles in the enzymatic mechanism of temperaturesolysin have equivalents in stromlysin, but that three residues implicated in the catalytic mechanism of Thermolysin are not represented in stamelysin.
Journal ArticleDOI
A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE).
Thomas A. Rano,Tracy Timkey,Erin P. Peterson,Jennifer Rotonda,Donald W. Nicholson,Joseph W. Becker,Kevin T. Chapman,Nancy A. Thornberry +7 more
TL;DR: The preferred sequence for ICE (WEHD) differs significantly from that found in human pro-interleukin-1beta (YVHD), which suggests that this protease may have additional endogenous substrates, consistent with evidence linking it to apoptosis and IL-1alpha production.
Journal ArticleDOI
Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein.
Andrew D. Ferguson,Brian M. McKeever,Shihua Xu,Douglas Wisniewski,Douglas K. Miller,Ting-Ting Yamin,Robert H. Spencer,Lin Chu,Feroze Ujjainwalla,Barry R. Cunningham,Jilly F. Evans,Joseph W. Becker +11 more
TL;DR: The structures show that inhibitors bind in membrane-embedded pockets of FLAP, which suggests how these inhibitors prevent arachidonic acid from binding to FLAP and subsequently being transferred to 5-lipoxygenase, thereby preventing leukotriene biosynthesis.